1. Home
  2. IIIN vs LXRX Comparison

IIIN vs LXRX Comparison

Compare IIIN & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

IIIN

Insteel Industries Inc.

HOLD

Current Price

$33.13

Market Cap

609.9M

Sector

Industrials

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.35

Market Cap

541.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIIN
LXRX
Founded
1953
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.9M
541.5M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
IIIN
LXRX
Price
$33.13
$1.35
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$3.23
AVG Volume (30 Days)
114.8K
1.5M
Earning Date
01-15-2026
11-06-2025
Dividend Yield
3.37%
N/A
EPS Growth
112.14
N/A
EPS
2.10
N/A
Revenue
$647,706,000.00
$70,864,000.00
Revenue This Year
$14.97
$56.61
Revenue Next Year
$7.00
N/A
P/E Ratio
$15.82
N/A
Revenue Growth
22.39
1255.21
52 Week Low
$22.49
$0.28
52 Week High
$41.64
$1.66

Technical Indicators

Market Signals
Indicator
IIIN
LXRX
Relative Strength Index (RSI) 63.13 46.47
Support Level $31.34 $1.29
Resistance Level $32.24 $1.48
Average True Range (ATR) 0.69 0.07
MACD 0.39 -0.01
Stochastic Oscillator 92.04 28.96

Price Performance

Historical Comparison
IIIN
LXRX

About IIIN Insteel Industries Inc.

Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: